Ginkgo Bioworks Expects To Meet FY23 Revenue Guidance Ranges

RTTNews | 692 dni temu
Ginkgo Bioworks Expects To Meet FY23 Revenue Guidance Ranges

(RTTNews) - Ahead of its presentation at the 42nd Annual J.P. Morgan Healthcare Conference later on Wednesday, Ginkgo Bioworks (DNA) said it expects to meet its previously disclosed new program and revenue guidance ranges in 2023, based on its preliminary unaudited estimates.

Fiscal 2023, the company continues to expect total revenue between $250 million and $260 million, with Cell Engineering revenue between $145 million and $150 million as well as Biosecurity revenue up to $110 million.

The company added that New Cell Programs are expected to be within the previously disclosed guidance range of 80 to 85 new Cell Programs added to the platform in 2023.

A business review, including a discussion of Ginkgo's platform services for large scale data generation and AI to enable biopharma R&D, will be featured in a presentation.

read more
Ginkgo Bioworks Acquires Microbial Innovation Firm AgBiome's Platform Assets

Ginkgo Bioworks Acquires Microbial Innovation Firm AgBiome's Platform Assets

Ginkgo Bioworks (DNA), which is building the leading platform for cell programming and biosecurity, announced Thursday the acquisition of microbial innovation firm AgBiome, Inc.'s platform assets, including over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant functional data and metadata, as well as AgBiome's development pipeline.
RTTNews | 600 dni temu
Ginkgo Bioworks To Acquire Zymergen In All-stock Deal

Ginkgo Bioworks To Acquire Zymergen In All-stock Deal

Cell programming firm Ginkgo Bioworks Holdings, Inc. (DNA) and biotechnology company Zymergen, Inc. (ZY) announced Monday they have entered into a definitive agreement under which Ginkgo will acquire Zymergen in an all-stock transaction that values Zymergen at an approximately $300 million market capitalization.
RTTNews | 1226 dni temu
Australian Market Trims Early Gains In Mid-market

Australian Market Trims Early Gains In Mid-market

The Australian stock market is trimming its early gains in mid-market moves on Wednesday, but extending the gains in the previous session, with the benchmark S&P/ASX 200 staying just below the 8,600 level, following the broadly positive cues from Wall Street overnight, with gains in financial and energy stocks partially offset by weakness in gold mining stocks.
RTTNews | 2g 28 minut temu